• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质体支持的腹膜透析用于药物和内源性代谢物的解毒。

Liposome-supported peritoneal dialysis for detoxification of drugs and endogenous metabolites.

机构信息

Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology, ETH Zurich, Vladimir Prelog Weg 1-5/10, 8093 Zurich, Switzerland.

出版信息

Sci Transl Med. 2014 Oct 15;6(258):258ra141. doi: 10.1126/scitranslmed.3009135.

DOI:10.1126/scitranslmed.3009135
PMID:25320233
Abstract

Peritoneal dialysis confers therapeutic advantages in patients with renal insufficiency and has proven beneficial in other indications, such as removal of excess metabolites or overdosed drugs. However, it is used in only about 10% of the dialyzed population worldwide, partly owing to the lower clearance rate compared with hemodialysis. We have developed a dialysis medium based on liposomes with a transmembrane pH gradient (basic or acidic aqueous core) that could improve the efficacy of peritoneal dialysis, specifically for the removal of excess metabolites or overdosed drugs. These scavenging vesicles are able to extract ionizable drugs and toxic metabolites into the peritoneal space and can be easily withdrawn from the body at the end of dialysis. This approach was used to successfully remove ammonia from rats with a greater extraction efficiency than traditional peritoneal dialysis, and may therefore prove useful in the treatment of severe hyperammonemia. Liposomal dialysis was also used to concentrate exogenous compounds in the rat peritoneal cavity, allowing for sequestration of several drugs that are frequently involved in overdose in people. In particular, liposomal dialysis counteracted the hypotensive action of the cardiovascular drug verapamil more efficiently than did control dialysis in a rat model of drug overdose. These findings highlight the versatility and advantage of this liposome-based approach for emergency dialysis.

摘要

腹膜透析在肾功能不全患者中具有治疗优势,并且已在其他适应证中得到证实有益,例如清除过多的代谢物或过量的药物。然而,它在全球约 10%的透析患者中使用,部分原因是与血液透析相比,其清除率较低。我们开发了一种基于脂质体的透析液,具有跨膜 pH 梯度(碱性或酸性水核),可提高腹膜透析的疗效,特别是用于清除过多的代谢物或过量的药物。这些清除囊泡能够将可离子化的药物和毒性代谢物提取到腹膜腔中,并在透析结束时轻松从体内取出。这种方法成功地从患有高氨血症的大鼠中去除了氨,其提取效率高于传统的腹膜透析,因此可能对治疗严重高氨血症有用。脂质体透析还用于在大鼠的腹膜腔中浓缩外源性化合物,从而可以隔离几种在人群中经常过量使用的药物。特别是,脂质体透析在药物过量的大鼠模型中比对照透析更有效地拮抗心血管药物维拉帕米的降压作用。这些发现强调了这种基于脂质体的方法在紧急透析中的多功能性和优势。

相似文献

1
Liposome-supported peritoneal dialysis for detoxification of drugs and endogenous metabolites.脂质体支持的腹膜透析用于药物和内源性代谢物的解毒。
Sci Transl Med. 2014 Oct 15;6(258):258ra141. doi: 10.1126/scitranslmed.3009135.
2
Liposome-supported peritoneal dialysis in the treatment of severe hyperammonemia: An investigation on potential interactions.脂质体支持的腹膜透析治疗严重高氨血症:潜在相互作用的研究。
J Control Release. 2018 May 28;278:57-65. doi: 10.1016/j.jconrel.2018.03.030. Epub 2018 Mar 27.
3
Peritoneal dialysis: nanoparticles have entered the game.腹膜透析:纳米颗粒已参与其中。
Perit Dial Int. 2015 May-Jun;35(3):240. doi: 10.3747/pdi.2015.00075.
4
Preclinical evaluation of liposome-supported peritoneal dialysis for the treatment of hyperammonemic crises.脂质体支持的腹膜透析治疗高氨血症危象的临床前评价。
J Control Release. 2020 Dec 10;328:503-513. doi: 10.1016/j.jconrel.2020.08.040. Epub 2020 Aug 26.
5
pH Gradient Liposomes Extract Protein Bound Amitriptyline in Peritoneal Dialysis-Exploratory Work.pH 梯度脂质体从腹膜透析液中提取蛋白结合的阿米替林:探索性工作。
Int J Mol Sci. 2022 Sep 30;23(19):11577. doi: 10.3390/ijms231911577.
6
Liposome-supported enzymatic peritoneal dialysis.脂质体支持的酶促腹膜透析。
Biomaterials. 2017 Nov;145:128-137. doi: 10.1016/j.biomaterials.2017.08.016. Epub 2017 Aug 14.
7
Liposomes to Augment Dialysis in Preclinical Models: A Structured Review.脂质体增强临床前模型中的透析:一项结构化综述。
Pharmaceutics. 2021 Mar 16;13(3):395. doi: 10.3390/pharmaceutics13030395.
8
Liposome supported peritoneal dialysis in rat amitriptyline exposure with and without intravenous lipid emulsion.脂质体支持的腹膜透析在大鼠中暴露于阿米替林以及是否联合静脉用脂肪乳剂。
J Liposome Res. 2019 Jun;29(2):114-120. doi: 10.1080/08982104.2017.1403445. Epub 2017 Dec 5.
9
[Peritoneal dialysis in the aged].[老年人的腹膜透析]
Med Pregl. 1999 Sep-Oct;52(9-10):369-74.
10
Comparison of three chronic dialysis models.
Adv Perit Dial. 2000;16:51-4.

引用本文的文献

1
3D printing injectable microbeads using a composite liposomal ink for local treatment of peritoneal diseases.使用复合脂质体墨水进行 3D 打印可注射微球,用于局部治疗腹膜疾病。
Drug Deliv Transl Res. 2024 Jun;14(6):1567-1581. doi: 10.1007/s13346-023-01472-y. Epub 2023 Nov 25.
2
Nanoantidotes: A Detoxification System More Applicable to Clinical Practice.纳米解毒剂:一种更适用于临床实践的解毒系统。
BME Front. 2023 May 18;2023:0020. doi: 10.34133/bmef.0020. eCollection 2023.
3
Lipid Emulsion to Treat Acute Poisonings: Mechanisms of Action, Indications, and Controversies.
用于治疗急性中毒的脂质乳剂:作用机制、适应证及争议
Pharmaceutics. 2023 May 3;15(5):1396. doi: 10.3390/pharmaceutics15051396.
4
Biomedical Nanosystems for In Vivo Detoxification: From Passive Delivery Systems to Functional Nanodevices and Nanorobots.用于体内解毒的生物医学纳米系统:从被动递送系统到功能性纳米器件和纳米机器人
Acta Naturae. 2023 Jan-Mar;15(1):4-12. doi: 10.32607/actanaturae.15681.
5
Engineering Lipid Spherulites for the Sustained Release of Highly Dosed Small Hydrophilic Compounds.工程化脂质球用于高剂量亲水性小分子化合物的持续释放。
Adv Healthc Mater. 2023 Apr;12(10):e2202249. doi: 10.1002/adhm.202202249. Epub 2023 Jan 13.
6
pH Gradient Liposomes Extract Protein Bound Amitriptyline in Peritoneal Dialysis-Exploratory Work.pH 梯度脂质体从腹膜透析液中提取蛋白结合的阿米替林:探索性工作。
Int J Mol Sci. 2022 Sep 30;23(19):11577. doi: 10.3390/ijms231911577.
7
Liposomes to Augment Dialysis in Preclinical Models: A Structured Review.脂质体增强临床前模型中的透析:一项结构化综述。
Pharmaceutics. 2021 Mar 16;13(3):395. doi: 10.3390/pharmaceutics13030395.
8
An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure.一种口服微生物混合物,用于清除肾衰竭动物模型中的氮代谢废物。
Nat Biomed Eng. 2020 Sep;4(9):853-862. doi: 10.1038/s41551-020-0582-1. Epub 2020 Jul 6.
9
Engineered Polymersomes for the Treatment of Fish Odor Syndrome: A First Randomized Double Blind Olfactory Study.用于治疗鱼腥味综合征的工程化聚合物囊泡:首例随机双盲嗅觉研究。
Adv Sci (Weinh). 2020 Mar 9;7(8):1903697. doi: 10.1002/advs.201903697. eCollection 2020 Apr.
10
Hepatic glutamine synthetase augmentation enhances ammonia detoxification.肝谷氨酰胺合成酶增强可提高氨解毒功能。
J Inherit Metab Dis. 2019 Nov;42(6):1128-1135. doi: 10.1002/jimd.12070. Epub 2019 Mar 11.